Additionally, a polymorphism at chr7_128586760 is associated with an increased susceptibility to SLE, indicating that alterations in IRF5 could lead to dysregulated immune responses, including the overactivation of type I interferon pathways, central to SLE’s pathology. This evidence concerns the gene IRF5 and systemic lupus erythematosus.